230 related articles for article (PubMed ID: 35691827)
1. Discovery of a Potent and Selective Degrader for USP7.
Pei Y; Fu J; Shi Y; Zhang M; Luo G; Luo X; Song N; Mi T; Yang Y; Li J; Zhou Y; Zhou B
Angew Chem Int Ed Engl; 2022 Aug; 61(33):e202204395. PubMed ID: 35691827
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of USP7 induces p53-independent tumor growth suppression in triple-negative breast cancers by destabilizing FOXM1.
Yi J; Li H; Chu B; Kon N; Hu X; Hu J; Xiong Y; Kaniskan HU; Jin J; Gu W
Cell Death Differ; 2023 Jul; 30(7):1799-1810. PubMed ID: 37291217
[TBL] [Abstract][Full Text] [Related]
3. Small-molecule inhibitor of USP7/HAUSP ubiquitin protease stabilizes and activates p53 in cells.
Colland F; Formstecher E; Jacq X; Reverdy C; Planquette C; Conrath S; Trouplin V; Bianchi J; Aushev VN; Camonis J; Calabrese A; Borg-Capra C; Sippl W; Collura V; Boissy G; Rain JC; Guedat P; Delansorne R; Daviet L
Mol Cancer Ther; 2009 Aug; 8(8):2286-95. PubMed ID: 19671755
[TBL] [Abstract][Full Text] [Related]
4. USP7/HAUSP promotes the sequence-specific DNA binding activity of p53.
Sarkari F; Sheng Y; Frappier L
PLoS One; 2010 Sep; 5(9):e13040. PubMed ID: 20885946
[TBL] [Abstract][Full Text] [Related]
5. Trip12 is an E3 ubiquitin ligase for USP7/HAUSP involved in the DNA damage response.
Liu X; Yang X; Li Y; Zhao S; Li C; Ma P; Mao B
FEBS Lett; 2016 Dec; 590(23):4213-4222. PubMed ID: 27800609
[TBL] [Abstract][Full Text] [Related]
6. (1)H, (13)C and (15)N backbone resonance assignment for the 40.5 kDa catalytic domain of Ubiquitin Specific Protease 7 (USP7).
Di Lello P; Rougé L; Pan B; Maurer T
Biomol NMR Assign; 2016 Oct; 10(2):345-9. PubMed ID: 27386854
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitin-specific protease 7 regulates nucleotide excision repair through deubiquitinating XPC protein and preventing XPC protein from undergoing ultraviolet light-induced and VCP/p97 protein-regulated proteolysis.
He J; Zhu Q; Wani G; Sharma N; Han C; Qian J; Pentz K; Wang QE; Wani AA
J Biol Chem; 2014 Sep; 289(39):27278-27289. PubMed ID: 25118285
[TBL] [Abstract][Full Text] [Related]
8. Modulation of the p53/MDM2 interplay by HAUSP inhibitors.
Tavana O; Gu W
J Mol Cell Biol; 2017 Feb; 9(1):45-52. PubMed ID: 27927749
[TBL] [Abstract][Full Text] [Related]
9. Recent advances on the intervention sites targeting USP7-MDM2-p53 in cancer therapy.
Harakandi C; Nininahazwe L; Xu H; Liu B; He C; Zheng YC; Zhang H
Bioorg Chem; 2021 Nov; 116():105273. PubMed ID: 34474304
[TBL] [Abstract][Full Text] [Related]
10. The RNA binding protein RALY suppresses p53 activity and promotes lung tumorigenesis.
Hu H; Zhao K; Fang D; Wang Z; Yu N; Yao B; Liu K; Wang F; Mei Y
Cell Rep; 2023 Apr; 42(4):112288. PubMed ID: 36952348
[TBL] [Abstract][Full Text] [Related]
11. USP7 inhibitor P22077 inhibits neuroblastoma growth via inducing p53-mediated apoptosis.
Fan YH; Cheng J; Vasudevan SA; Dou J; Zhang H; Patel RH; Ma IT; Rojas Y; Zhao Y; Yu Y; Zhang H; Shohet JM; Nuchtern JG; Kim ES; Yang J
Cell Death Dis; 2013 Oct; 4(10):e867. PubMed ID: 24136231
[TBL] [Abstract][Full Text] [Related]
12. Selective USP7 inhibition elicits cancer cell killing through a p53-dependent mechanism.
Schauer NJ; Liu X; Magin RS; Doherty LM; Chan WC; Ficarro SB; Hu W; Roberts RM; Iacob RE; Stolte B; Giacomelli AO; Perera S; McKay K; Boswell SA; Weisberg EL; Ray A; Chauhan D; Dhe-Paganon S; Anderson KC; Griffin JD; Li J; Hahn WC; Sorger PK; Engen JR; Stegmaier K; Marto JA; Buhrlage SJ
Sci Rep; 2020 Mar; 10(1):5324. PubMed ID: 32210275
[TBL] [Abstract][Full Text] [Related]
13. C-terminal region of USP7/HAUSP is critical for deubiquitination activity and contains a second mdm2/p53 binding site.
Ma J; Martin JD; Xue Y; Lor LA; Kennedy-Wilson KM; Sinnamon RH; Ho TF; Zhang G; Schwartz B; Tummino PJ; Lai Z
Arch Biochem Biophys; 2010 Nov; 503(2):207-12. PubMed ID: 20816748
[TBL] [Abstract][Full Text] [Related]
14. USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.
Saha G; Sarkar S; Mohanta PS; Kumar K; Chakrabarti S; Basu M; Ghosh MK
Oncogene; 2022 Nov; 41(47):5061-5075. PubMed ID: 36243803
[TBL] [Abstract][Full Text] [Related]
15. USP7: Target Validation and Drug Discovery for Cancer Therapy.
Zhou J; Wang J; Chen C; Yuan H; Wen X; Sun H
Med Chem; 2018; 14(1):3-18. PubMed ID: 29065837
[TBL] [Abstract][Full Text] [Related]
16. Identification of Kaposi Sarcoma Herpesvirus (KSHV) vIRF1 Protein as a Novel Interaction Partner of Human Deubiquitinase USP7.
Chavoshi S; Egorova O; Lacdao IK; Farhadi S; Sheng Y; Saridakis V
J Biol Chem; 2016 Mar; 291(12):6281-91. PubMed ID: 26786098
[TBL] [Abstract][Full Text] [Related]
17. STIP is a critical nuclear scaffolding protein linking USP7 to p53-Mdm2 pathway regulation.
Ye M; Tang Y; Tang S; Liu J; Wu K; Yao S; Sun Y; Zhou L; Deng T; Chen Y; Huang C; Tan W
Oncotarget; 2015 Oct; 6(33):34718-31. PubMed ID: 26460617
[TBL] [Abstract][Full Text] [Related]
18. TSPYL5 suppresses p53 levels and function by physical interaction with USP7.
Epping MT; Meijer LA; Krijgsman O; Bos JL; Pandolfi PP; Bernards R
Nat Cell Biol; 2011 Jan; 13(1):102-8. PubMed ID: 21170034
[TBL] [Abstract][Full Text] [Related]
19. Protein interaction domains of the ubiquitin-specific protease, USP7/HAUSP.
Holowaty MN; Sheng Y; Nguyen T; Arrowsmith C; Frappier L
J Biol Chem; 2003 Nov; 278(48):47753-61. PubMed ID: 14506283
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of USP7/HAUSP activation by its C-terminal ubiquitin-like domain and allosteric regulation by GMP-synthetase.
Faesen AC; Dirac AM; Shanmugham A; Ovaa H; Perrakis A; Sixma TK
Mol Cell; 2011 Oct; 44(1):147-59. PubMed ID: 21981925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
